Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations . Rev Diabet Stud [Internet]. 2023 Aug. 13 [cited 2025 Sep. 20];6(1). Available from: https://www.diabeticstudies.org/index.php/RDS/article/view/252